Tavexia Lifecare to buy 60% stake in Meyonex for ₹67.19 crore

Tavexia Lifecare has approved a ₹67.19 crore investment to acquire a 60% controlling stake in Meyonex Pharmaceuticals. The deal marks a major shift towards pharma manufacturing, formulations and CDMO services, while the company is also exploring fresh fund-raising options to support the acquisition and expansion.